本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Phathom Pharmaceuticals

3.25
-0.0600-1.81%
盤後3.360.1093+3.36%17:02 EDT
成交量:206.75萬
成交額:698.22萬
市值:2.26億
市盈率:-0.63
高:3.65
開:3.40
低:3.20
收:3.31
資料載入中...
2024/06/06

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/10

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/01

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/07

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/07

重要事件披露

Form 8-K - Current report
2024/02/13

重要事件披露

Form 8-K - Current report
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/26

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/25

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/15

重要事件披露

Form 8-K - Current report
2023/12/14

重要事件披露

Form 8-K - Current report
2023/12/06

重要事件披露

Form 8-K - Current report
2023/11/28

重要事件披露

Form 8-K - Current report
2023/11/16

SEC問詢函

Form CORRESP - Correspondence
2023/11/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report